Treatment

Setrusumab clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2, PHASE3
Setrusumab vs Placebo for Osteogenesis Imperfecta
This study is testing a new medicine, Setrusumab, for people aged 5-25 with Osteogenesis Imperfecta (brittle bone disease). It aims to see if Setrusumab can reduce bone fractures compared to a dummy treatment (placebo) and find the best dose.
For: Osteogenesis Imperfecta
United States · Australia · Canada